MedTrace Logo

Association of Macular Pigment Optical Density (MPOD) and Genetic Variants in Complement Factor H in Subjects With Choroidal Neovascular (CNV)

NCT01682382 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2014-01-20

No results posted yet for this study

Summary

Subjects with wet AMD, dry AMD, and age-matched controls will undergo routine occular measurements, will provide a blood and cheek cell sample, and will have macular pigment optical density (MPOD) measured to determine if there is an association between genetics, MPOD and the risk of progression to wet AMD.

Conditions

  • Age-related Macular Degeneration
  • Choroidal Neovascular Age-related Macular Degeneration

Sponsors & Collaborators

  • Sequenom, Inc.

    lead INDUSTRY

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2013-08-31
Completion
2013-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01682382 on ClinicalTrials.gov